Zdrowie i gospodarka · 14/08/2012

FDA to Discuss Study Data Exchange Standards at Upcoming Meeting

The Food and Drug Administration (FDA) is hosting a meeting to gather input from industry, technology vendors, and the public on the advantages and disadvantages of current and emerging open, consensus-based standards for exchanging regulated study data, as well as premeeting questions.